Table 3.
Percentage of resistance for drug susceptibility discordant and heteroresistance cases
| Frequency | RIF | INH | History of treatment | ||
|---|---|---|---|---|---|
| Discordant | MDR | 1 | 5.9–11.8 | 5.9–11.9 | Retreatment |
| 1 | 16.6–41.6 | _ | Retreatment | ||
| 1 | 11.8–29.4 | _ | Retreatment | ||
| 1 | _ | 3.3–6.6 | Retreatment | ||
| 1 | _ | 6.2–12.5 | Retreatment | ||
| RIF | 1 | 10.0–25.0 | _ | Retreatment | |
| INH | 1 | _ | 10.0–20.0 | New | |
| 1 | _ | 1.0–2.0 | New | ||
| Heteroresistance | MDR | 1 | 1.0–2.0 | _ | New |
| 1 | _ | 1.0–2.0 | New | ||
| INH | 1 | _ | 2.0–5.0 | New | |
| 1 | _ | 2.0–4.0 | New | ||
| 1 | _ | 1.0–4.0 | Retreatment | ||
| 1 | _ | 2.4–5.0 | New | ||
| 1 | _ | 2.0–10.0 | Retreatment | ||
| 1 | _ | 1.6 | New | ||
| 1 | _ | 2.0–10.0 | New | ||
| 1 | _ | 1.0–5.0 | Retreatment | ||
| 2 | _ | 2.0–10.0 | New |
MDR: multidrug resistant; RIF: rifampicin; INH: isoniazid